Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomyelitis, Autoimmune, Experimental | 12 | 2023 | 50 | 3.470 |
Why?
|
| Multiple Sclerosis | 7 | 2023 | 77 | 1.670 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2018 | 30 | 1.210 |
Why?
|
| Interleukin-12 Subunit p40 | 3 | 2020 | 20 | 0.990 |
Why?
|
| Th17 Cells | 5 | 2020 | 23 | 0.980 |
Why?
|
| Adoptive Transfer | 3 | 2017 | 31 | 0.930 |
Why?
|
| Sodium Chloride | 2 | 2017 | 32 | 0.910 |
Why?
|
| Mice | 16 | 2023 | 1233 | 0.840 |
Why?
|
| Animals | 17 | 2023 | 3253 | 0.730 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2020 | 13 | 0.700 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 514 | 0.670 |
Why?
|
| Interleukin-11 | 1 | 2018 | 5 | 0.600 |
Why?
|
| Aspirin | 1 | 2018 | 47 | 0.570 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 90 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 8 | 2023 | 355 | 0.560 |
Why?
|
| Th1 Cells | 2 | 2018 | 23 | 0.550 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2017 | 13 | 0.530 |
Why?
|
| Peptides | 2 | 2018 | 89 | 0.510 |
Why?
|
| Plant Extracts | 1 | 2015 | 13 | 0.460 |
Why?
|
| Parkinsonian Disorders | 2 | 2019 | 158 | 0.450 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 16 | 0.430 |
Why?
|
| NF-kappa B | 2 | 2021 | 104 | 0.410 |
Why?
|
| Cells, Cultured | 6 | 2021 | 470 | 0.410 |
Why?
|
| Interleukin-23 | 3 | 2023 | 14 | 0.330 |
Why?
|
| Interleukin-12 | 3 | 2023 | 34 | 0.330 |
Why?
|
| Dopaminergic Neurons | 2 | 2021 | 39 | 0.320 |
Why?
|
| Microglia | 3 | 2023 | 108 | 0.320 |
Why?
|
| Female | 11 | 2020 | 13031 | 0.320 |
Why?
|
| Protein Multimerization | 1 | 2009 | 14 | 0.310 |
Why?
|
| Peptide Fragments | 3 | 2018 | 57 | 0.310 |
Why?
|
| PPAR-beta | 2 | 2023 | 10 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 167 | 0.290 |
Why?
|
| Cinnamomum zeylanicum | 3 | 2016 | 16 | 0.260 |
Why?
|
| Food Preservatives | 2 | 2016 | 8 | 0.250 |
Why?
|
| Sodium Benzoate | 2 | 2016 | 15 | 0.240 |
Why?
|
| Blood-Brain Barrier | 2 | 2016 | 22 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2021 | 398 | 0.240 |
Why?
|
| Oligodendroglia | 2 | 2015 | 27 | 0.210 |
Why?
|
| Myelin Sheath | 2 | 2015 | 21 | 0.210 |
Why?
|
| RNA, Messenger | 4 | 2023 | 279 | 0.200 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2021 | 18 | 0.190 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 168 | 0.190 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2021 | 32 | 0.190 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2018 | 28 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 175 | 0.180 |
Why?
|
| Protein Binding | 1 | 2020 | 114 | 0.170 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 102 | 0.160 |
Why?
|
| Chemokine CCL5 | 1 | 2019 | 9 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 228 | 0.160 |
Why?
|
| Substantia Nigra | 1 | 2019 | 98 | 0.150 |
Why?
|
| Myelin Proteolipid Protein | 2 | 2016 | 6 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 319 | 0.140 |
Why?
|
| Demyelinating Diseases | 2 | 2015 | 12 | 0.140 |
Why?
|
| Astrocytes | 2 | 2015 | 127 | 0.130 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2016 | 2 | 0.130 |
Why?
|
| Hippocampus | 1 | 2018 | 199 | 0.130 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 10 | 0.130 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 148 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 55 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2016 | 88 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 82 | 0.120 |
Why?
|
| Humans | 11 | 2023 | 23152 | 0.120 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2015 | 8 | 0.120 |
Why?
|
| Inflammation | 2 | 2018 | 232 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2015 | 16 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2015 | 98 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 78 | 0.110 |
Why?
|
| Male | 3 | 2020 | 12524 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2015 | 70 | 0.110 |
Why?
|
| Interleukin-7 | 1 | 2014 | 12 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 1 | 2014 | 16 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 84 | 0.100 |
Why?
|
| Primary Cell Culture | 3 | 2021 | 24 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 29 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 37 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2012 | 102 | 0.100 |
Why?
|
| Incidence | 1 | 2015 | 634 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2012 | 130 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 131 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2012 | 73 | 0.100 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hypolipidemic Agents | 1 | 2012 | 23 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2012 | 56 | 0.100 |
Why?
|
| Gemfibrozil | 1 | 2012 | 29 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 186 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 129 | 0.090 |
Why?
|
| Cytokines | 1 | 2012 | 204 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2021 | 278 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 169 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2016 | 143 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 1196 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2009 | 13 | 0.080 |
Why?
|
| Myelin Basic Protein | 1 | 2009 | 20 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 1308 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 93 | 0.070 |
Why?
|
| Adult | 1 | 2020 | 7038 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2005 | 11 | 0.070 |
Why?
|
| Disease Progression | 1 | 2009 | 519 | 0.070 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2005 | 7 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 42 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 70 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 148 | 0.060 |
Why?
|
| Parkinson Disease | 2 | 2021 | 587 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2023 | 21 | 0.050 |
Why?
|
| Valerates | 1 | 2023 | 2 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 4 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 7 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 89 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 40 | 0.050 |
Why?
|
| Proteinuria | 1 | 2003 | 48 | 0.050 |
Why?
|
| Hypertension | 1 | 2003 | 157 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 17 | 0.050 |
Why?
|
| Multiple System Atrophy | 1 | 2021 | 25 | 0.040 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 67 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 327 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 34 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 196 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2016 | 4 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2016 | 2 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2016 | 10 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 2016 | 5 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 11 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 32 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2015 | 35 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 41 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 44 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 111 | 0.030 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 4 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Luciferases | 1 | 2014 | 25 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 22 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 117 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 86 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2012 | 13 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 13 | 0.020 |
Why?
|
| RNA Stability | 1 | 2005 | 1 | 0.020 |
Why?
|
| Elongin | 1 | 2005 | 2 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 30 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 127 | 0.020 |
Why?
|
| Placenta Growth Factor | 1 | 2003 | 1 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 1 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 8 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 8 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 20 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 59 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 46 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 143 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 318 | 0.010 |
Why?
|